Raphael D.
- Country
- The Netherlands
- Department
- N/A
Research Overview
- Evaluation of Zr-89 Crefmirlimab PET Imaging for CD8+ T Cell Assessment in Renal Allograft Rejection
- A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy
- Evaluation of Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sibeprenlimab in Patients with Immunoglobulin A Nephropathy
Data & Insights
Has run more than one trial at 69 of 183 partner sites.
Specializations
Glomerular Diseases
This investigator specializes in the study and treatment of glomerular disorders, with particular emphasis on Immunoglobulin A Nephropathy (IgAN). Their research focuses on innovative therapeutic approaches for managing kidney function and reducing proteinuria in IgAN patients.
- IgA Nephropathy management
- Proteinuria reduction strategies
- Kidney function preservation
The investigator evaluates novel therapeutic agents targeting IgAN pathways to improve patient outcomes.
Complement-Mediated Kidney Disorders
A significant focus of research involves complement 3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN). The investigator studies therapeutic interventions for these complement-mediated kidney conditions.
- C3G treatment approaches
- IC-MPGN management
- Post-transplant recurrence therapy
Their work includes evaluation of complement-targeting treatments for these rare kidney disorders.
Long-term Treatment Outcomes
The investigator conducts research on long-term safety and efficacy of various therapeutic interventions in kidney diseases. Their work encompasses extended monitoring of treatment responses in glomerular disorders.
- Treatment durability assessment
- Safety profile evaluation
- Long-term disease management
Focus includes monitoring sustained therapeutic effects in chronic kidney conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.